Luu Brendan Insider Trades

Insider Trading History

Track insider trading activity for Luu Brendan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $631k 44,891 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.8k 6,562 shares
$13.84
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $585k 41,634 shares
Last Trade
Feb 12, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$46.4k 3,257 shares
$14.25
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $539k 38,329 shares
Last Trade
Dec 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.8k 1,394 shares
$14.23
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $559k 39,723 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.03k 498 shares
$14.12
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $1.27M 90,000 shares
Last Trade
Nov 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 90,000 shares
$13.66
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $612k 43,547 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 7,500 shares
$5.86
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $566k 40,221 shares
Last Trade
Feb 12, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.6k 3,326 shares
$5.59
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $507k 36,047 shares
Last Trade
Dec 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.4k 2,283 shares
$8.06
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $539k 38,330 shares
Last Trade
Dec 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.48k 753 shares
$8.60
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $1.05M 75,000 shares
Last Trade
Nov 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662k 75,000 shares
$8.83
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $550k 39,083 shares
Last Trade
Feb 12, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.1k 973 shares
$12.41
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Business Officer
Holding Value $563k 40,056 shares
Last Trade
Feb 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.9k 3,320 shares
$12.33
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $517k 36,736 shares
Last Trade
Dec 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.5k 2,125 shares
$9.63
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $546k 38,861 shares
Last Trade
Dec 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.15k 753 shares
$9.49
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $1.17M 83,000 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 83,000 shares
$8.99
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $557k 39,614 shares
Last Trade
Feb 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$339k 6,416 shares
$52.77
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $362k 25,725 shares
Last Trade
Dec 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.1k 498 shares
$44.33
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $562k 40,000 shares
Last Trade
Nov 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.63M 58,500 shares
$45.00
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $109k 7,723 shares
Last Trade
Feb 14, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$30.6k 489 shares
$62.49
$14.06
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, Business Dev.
Holding Value $115k 8,212 shares
Last Trade
Feb 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.1k 1,412 shares
$60.96
$14.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up